Drugs / HSP990
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01064089 | Feb 2010 → Jan 2012 | cancer | Novartis Pharmaceuticals | Terminated | No outcome recorded |
| Phase 1 | NCT00879905 | May 2009 → Jul 2012 | high grade malignant neoplasm | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HSP990 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00879905 ↗ |
| Route | Oral | “given by mouth” NCT00879905 ↗ |